Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Nov;90(11):1238–1243. doi: 10.1111/j.1349-7006.1999.tb00702.x

Differential Expression of Facilitative Glucose Transporter (GLUT) Genes in Primary Lung Cancers and Their Liver Metastases

Takayasu Kurata 1, Tetsuya Oguri 1, Takeshi Isobe 1,✉, Shin‐ichi Ishioka 1, Michio Yamakido 1
PMCID: PMC5926010  PMID: 10622535

Abstract

Glucose uptake is mediated by members of the facilitative glucose transporter (GLUT) family. Malignant cells take up more glucose than their normal counterparts. The aim of this study was to investigate the gene expression levels of the GLUT family, especially GLUT1, GLUT3, and GLUT5 in primary lung cancer, metastatic liver tumors, and normal lung tissues, and to compare the expression levels of primary and metastatic tumors with those of normal tissues. We analyzed 105 autopsy samples (35 primary lung tumors, 35 corresponding normal lung tissues, 25 normal liver tissues, and 10 metastatic liver tumors) from 35 patients using the quantitative reverse transcription polymerase chain reaction. The GLUT1 gene expression levels in primary lung tumors were significantly higher than those in normal lung tissues. In liver metastatic lesions, the GLUT3 and GLUT5 gene expression levels were significantly higher than those in primary lung tumors, but there were no differences in GLUT1 expression levels between primary and metastatic liver tumors. Our results show that the gene expression pattern of the GLUT family is different between primary and metastatic liver tumors and suggest that the energy transporters in metastatic tumors may be different from those in primary tumors.

Keywords: GLUT1, GLUT3, GLUT5, Lung cancer, Metastatic lesion

Full Text

The Full Text of this article is available as a PDF (93.5 KB).

REFERENCES

  • 1. ) Hatanaka , M.Transport of sugars in tumor cell membranes . Biochim. Biophys. Acta , 355 , 77 – 104 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Isselbacher , K. J.Sugar and amino acid transport by cells in culture—differences between normal and malignant cells . N. Engl. J. Med. , 286 , 929 – 933 ( 1972. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Holm , E. , Hagmüller , E. , Staedt , U. , Schlickeiser , G. , Günther , H.‐J. , Leweling , H. , Tokus , M. and Kollmar , H. B.Substrate balances across colonic carcinomas in Humans . Cancer Res. , 55 , 1373 – 1378 ( 1995. ). [PubMed] [Google Scholar]
  • 4. ) Mueckler , M. , Caruso , C. , Baldwin , S. A. , Panico , M. , Blench , I. , Morris , H. R. , Allard , W. J. , Lienhard , G. E. and Lodish , H. F.Sequence and structure of a human glucose transporter . Science , 229 , 941 – 945 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Fukumoto , H. , Seino , S. , Imura , H. , Seino , Y. , Eddy , R. L. , Fukushima , Y. , Byers , M. G. , Shows , T. B. and Bell , G. I.Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter‐like protein . Proc. Natl. Acad. Sci. USA , 85 , 5434 – 5438 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Kayano , T. , Fukumoto , H. , Eddy , R. L. , Fan , Y.‐S. , Byers , M. G. , Shows , T. B. and Bell , G. I.Evidence for a family of human glucose transporter‐like proteins: sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues . J. Biol. Chem. , 263 , 15245 – 15248 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Fukumoto , H. , Kayano , T. , Buse , J. B. , Edwards , Y. , Pilch , P. F. , Bell , G. I. and Seino , S.Cloning and characterization of the major insulin‐responsive glucose transporter expressed in human skeletal muscle and other insulin‐responsive tissues . J. Biol. Chem. , 264 , 7776 – 7779 ( 1989. ). [PubMed] [Google Scholar]
  • 8. ) Kayano , T. , Burant , C. F. , Fukumoto , H. , Gould , G. W. , Fan , Y.‐S. , Eddy , R. L. , Byers , M. G. , Shows , T. B. , Seino , S. and Bell , G. I.Human facilitative glucose transporters: isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene‐like sequence (GLUT6) . J. Biol. Chem. , 265 , 13276 – 13282 ( 1990. ). [PubMed] [Google Scholar]
  • 9. ) Waddell , I. D. , Zomerschoe , A. G. , Voice , M. W. and Burchell , A.Cloning and expression of a hepatic microsomal glucose transport protein: comparison with liver plasma‐membrane glucose‐transport protein GLUT2 . Biochem. J. , 286 , 173 – 177 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Pessin , J. E. and Bell , G. I.Mammalian facilitative glucose transporter family: structure and molecular regulation . Annu. Rev. Physiol. , 54 , 911 – 930 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Mueckler , M.Facilitative glucose transporters . Eur. J. Biochem. , 219 , 713 – 725 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Takata , K. , Kasahara , T. , Kasahara , M. , Ezaki , O. and Hirano , H.Erythrocyte/HepG2‐type glucose transporter is concentrated in cells of blood‐tissue barriers . Biochem. Biophys. Res. Commun. , 173 , 67 – 73 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Yamamoto , T. , Seino , Y. , Fukumoto , H. , Koh , G. , Yano , H. , Inagaki , N. , Yamada , Y. , Inoue , K. , Manabe , T. and Imura , H.Over‐expression of facilitative glucose transporter genes in human cancer . Biochem. Biophys. Res. Commun. , 170 , 223 – 230 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Brown , R. S. and Wahl , R. L.Overexpression of Glut‐1 glucose transporter in human breast cancer . Cancer , 72 , 2979 – 2985 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Mellanen , P. , Minn , H. , Grénman , R. and Härkönen , P.Expression of glucose transporters in head‐and‐neck tumors . Int. J. Cancer , 56 , 622 – 629 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Younes , M. , Lechago , L. V. , Somoano , J. R. , Mosharaf , M. and Lechago , J.Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers . Cancer Res. , 56 , 1164 – 1167 ( 1996. ). [PubMed] [Google Scholar]
  • 17. ) Haber , R. S. , Weiser , K. R. , Pritsker , A. , Reder , I. and Burstein , D. E.GLUT1 glucose transporter expression in benign and malignant thyroid nodules . Thyroid , 7 , 363 – 367 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Ogawa , J. , Inoue , H. and Koide , S.Glucose‐transporter‐type‐I‐gene amplification correlates with sialyl‐Lewis‐X synthesis and proliferation in lung cancer . Int. J. Cancer , 74 , 189 – 192 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Younes , M. , Lechago , L. V. , Somoano , J. R. , Mosharaf , M. and Lechago , J.Immunohistochemical detection of Glut3 in human tumors and normal tissues . Anticancer Res. , 17 , 2747 – 2750 ( 1997. ). [PubMed] [Google Scholar]
  • 20. ) Zamora‐León , S. P. , Golde , D. W. , Concha , I. I. , Rivas , C. I. , Delgado‐López , F. , Baselga , J. , Nualart , F. and Vera , J. C.Expression of the fructose transporter GLUT5 in human breast cancer . Proc. Natl. Acad. Sci. USA , 93 , 1847 – 1852 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Younes , M. , Brown , R. W. , Stephenson , M. , Gondo , M. and Cagle , P. T.Overexpression of Glut1 and Glut3 in Stage I nonsmall cell lung carcinoma is associated with poor survival . Cancer , 80 , 1046 – 1051 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Ito , T. , Noguchi , Y. , Satoh , S. , Hayashi , H. , Inayama , Y. and Kitamura , H.Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage . Mod. Pathol. , 11 , 437 – 443 ( 1998. ). [PubMed] [Google Scholar]
  • 23. ) Oguri , T. , Fujiwara , Y. , Isobe , T. , Katoh , O. , Watanabe , H. and Yamakido , M.Expression of γ‐glutamylcysteine synthetase (γ‐GCS) and multidrug resistance‐associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs . Br. J. Cancer , 77 , 1089 – 1096 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Kan , O. , Baldwin , S. A. and Whetton , A. D.Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line . J. Exp. Med. , 180 , 917 – 923 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Shim , H. , Chun , Y. S. , Lewis , B. C. and Dang , C. V.A unique glucose‐dependent apoptotic pathway induced by c‐Myc . Proc. Natl. Acad. Sci. USA , 95 , 1511 – 1516 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Martell , R. L. , Slapak , C. A. and Levy , S. B.Effect of glucose transport inhibitors on vincristine efflux in multidrug‐resistant murine erythroleukaemia cells overexpressing the multidrug resistance‐associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3 . Br. J. Cancer , 75 , 161 – 168 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Vera , J. C. , Castillo , G. R. and Rosen , O. M.A possible role for a mammalian facilitative hexose transporter in the development of resistance to drugs . Mol. Cell. Biol. , 11 , 3407 – 3418 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES